Skip to main content
Dexcom's continuous glucose monitoring system cleared by FDA
10/9/2019

Dexcom has obtained 510(k) clearance from the FDA for its G6 Pro Continuous Glucose Monitoring System, which gathers real-time glucose data for 10 days in a blinded and unblinded mode. The device is indicated for patients ages two years and older.

Full Story: